Entresto 24 MG-26 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DR26FY7ZE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,383
Award facts
- Contract value 100% obligated
- $33,383.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,383.38 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count). This firm fixed-price delivery order, awarded on October 28, 2025, with an ultimate completion date of October 29, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company fulfills this order through its existing relationship with the DLA as a prime contractor under its Indefinite Delivery Contract (IDC) vehicle.
This delivery order falls under AmerisourceBergen Drug Corp's comprehensive IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare programs worldwide. Entresto, a cardiovascular medication used in heart failure treatment, represents one of the specialized brand-name pharmaceuticals within the company's extensive federal contract portfolio. The order supports the Defense Health Agency and other government healthcare systems' medication supply requirements, demonstrating AmerisourceBergen Drug Corp's continued role as a key supplier of essential pharmaceuticals to the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FY7ZE?
SPE2DR26FY7ZE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FY7ZE worth?
The government has obligated $33,383 on SPE2DR26FY7ZE.
Is contract SPE2DR26FY7ZE an order under another contract?
Yes. SPE2DR26FY7ZE is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY7ZE competed?
The extent of competition for SPE2DR26FY7ZE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award